Tumor of uterus

Related records

Broader conditions (12)

• Cancer or benign tumor
• Disease
• Disease by body system or component
• Disease by etiologic mechanism
• Female reproductive system disorder
• Female reproductive system neoplasm
• Human disease
• Neoplasm
• Neoplastic disease or syndrome
• Reproductive system disorder
• Reproductive system neoplasm
• Uterine disorder

Narrower conditions (159)

• Adenoid cystic carcinoma of the corpus uteri
• Adenomyoma of uterine corpus
• Benign neoplasm of corpus uteri
• Benign neoplasm of endometrium
• Benign neoplasm of placenta
• Benign uterine ligament neoplasm
• Broad ligament malignant neoplasm
• Carcinosarcoma of the corpus uteri
• Cervical adenocarcinoma
• Cervical adenofibroma
• Cervical adenoid basal carcinoma
• Cervical adenoid cystic carcinoma
• Cervical adenosarcoma
• Cervical adenosquamous carcinoma
• Cervical adenosquamous carcinoma, glassy cell variant
• Cervical alveolar soft part sarcoma
• Cervical basaloid carcinoma
• Cervical benign neoplasm
• Cervical cancer
• Cervical carcinoma

Trials (243)

• [18F]FES PET/.CT in Uterine Cancer
• A Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
• A Global Assessment of Medical, Emotional and Reproductive Concerns in Gestational Trophoblastic Disease Survivors
• A Mind-body Intervention to Improve Body and/or Self Image
• A Pharmacodynamic Study of Leuprorelin Gelatin-Free Formulation in Female Subjects With Uterine Fibroids.
• A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
• A Phase I Study of CCI-779 (Temsirolimus) in Combination With Topotecan in Patients With Gynecologic Malignancies
• A Phase II Study of Paclitaxel and Carboplatin in Patients With an Elevated-Risk Cancer of the Uterus
• A Phase II Study of Therapy With Paclitaxel, Carboplatin and Megesterol Acetate for the Management of Uterine Cancer
• A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
• A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers
• A Pilot, Open-label Study of 18F-Fluciclatide PET/CT Imaging in the Evaluation of Anti-angiogenic Therapy in Solid Tumors
• A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE)
• A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
• A Retrospective Study on Multiple Classifier Endometrial Cancer
• A Study Assessing the Safety and Utility of PINPOINT® Near Infrared Fluorescence Imaging in the Identification of Lymph Nodes in Patients With Uterine and Cervical Malignancies Who Are Undergoing Lymph Node Mapping
• A Study of ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry Study
• A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma
• A Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors
• A Study of Nivolumab in Selected Uterine Cancer Patients

Drugs in development (21)

• Afatinib Phase 2
• Capivasertib Phase 1
• Carboplatin Phase 3
• Cisplatin Phase 3
• Docetaxel Phase 2
• Doxorubicin hydrochloride Phase 3
• Enzalutamide Phase 2
• Filgrastim Phase 3
• Fluorouracil Phase 2
• Gefitinib Phase 2
• Gemcitabine hydrochloride Phase 2
• Letrozole Phase 2
• Leucovorin Phase 2
• Olaparib Phase 1
• Oxaliplatin Phase 2
• Paclitaxel Phase 3
• Pegfilgrastim Phase 3
• Ribociclib Phase 2
• Selumetinib Phase 2
• Topotecan Phase 2